CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Hiring the Right CRO to Improve Clinical Trial Outcomes

Hiring the Right CRO to Improve...

 Altasciences Receives Accreditation From College Of American Pathologists

Altasciences Receives Accreditation...

Life Science Marketing: Content Distribution for Businesses

Life Science Marketing: Content...

Protypia, Inc.'S Acquisition By Inotiv, Inc. Broadens The Company's Protein/Peptide Bioanalytical Capabilities

Protypia, Inc.'S Acquisition By...

Making the Most of Contract Research Organization Relationships

Making the Most of Contract Research...

How Cloudbased Lims Helps Cros

How Cloudbased Lims Helps Cros

MMS Holdings Announces New Pro-Bono Support Program

MMS Holdings Announces New Pro-Bono...

Inotiv Secures MilliporeSigmas BioReliance Genetic Toxicology Assets

Inotiv Secures MilliporeSigmas...

Chiesi USA Makes Changes to its Organizational Leadership

Life Sciences Review Life Sciences Review | Wednesday, June 16, 2021
Tweet

Dr. Paolo Chiesi, Vice President of the Chiesi Group and President of the Foundation since its inception, is succeeded by Maria Paola Chiesi, former Coordinator of the Foundation since 2010.


FREMONT, CA: Chiesi USA (key-ay-zee), the U.S. subsidiary of Chiesi Farmaceutici, an international research-focused Healthcare Group (Chiesi Group), announced the appointment of Maria Paola Chiesi as the President of the Chiesi Foundation, a non-profit organization founded in 2005 as an expression of the corporate social engagement of the Chiesi Group.


The foundation’s major goal is to improve access to newborn and respiratory quality treatment in countries with low to medium levels of resources through research and international cooperation projects in the field of global health. Dr. Paolo Chiesi, Vice President of the Chiesi Group and President of the Foundation since its inception, is succeeded by Maria Paola Chiesi, former Coordinator of the Foundation since 2010.


“I would like to thank the Chiesi Foundation Board of Directors for this appointment, which I am proud to accept with humility and gratitude, and which I will hold with the same dedication that has characterized the work of Dr. Paolo Chiesi over the past few years. I care very much about the foundation, its commitment beyond company boundaries,” said Maria Paola Chiesi, Shared Value & Sustainability Head of the Chiesi Group and elected President of the Chiesi Foundation. I immediately believed in the value of strategic philanthropy, combining economic resources and know-how to have a wider social impact and an active role in helping to solve the complexities that characterize our society. 


With this in mind, I traveled in 2010 to Burkina Faso, in sub-Saharan Africa, to visit the neonatal clinic of the San Camillo Hospital in Ouagadougou. From that visit, and from a deeper reflection on the inequalities of access to quality care, the NEST (Neonatal Essential Survival Technologies) project came about.”


The Chiesi Foundation works in the field of international health cooperation by sharing scientific information and resources and funding programs that promote the right to health of the world’s poorest people, focusing on newborn and respiratory health. Projects incorporate the NEST (Neonatal Essential Survival Technology) model, which seeks to reduce neonatal mortality rates by advancing the quality of care in those areas where access to quality care is not yet assured, and the GASP project (Global Access to Spirometry Project), which focuses on the advancement of specific clinical skills for the determination and management of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) through the application of spirometry.


Massimo Salvadori, who joined the Chiesi Foundation as Coordinator in February, supports Maria Paola Chiesi in creating and expanding collaborations with key stakeholders (local partners, NGOs, government agencies, and scientific organizations) and project management. Massimo began his professional career in international collaboration with Médecins du Monde (MdM), where he worked in Sierra Leone, Algeria, Mali, and Senegal on global health programs. He most recently worked as the Area Programme Manager for Western Africa at COOPI - International Cooperation.


Weekly Brief

loading
Top 10 Preeminent Cros – 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/chiesi-usa-makes-changes-to-its-organizational-leadership-nwid-398.html